| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.2 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.098 | 0.2 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |